Larry D. Stonesifer

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 94 citations · Full text

Obesity, Metabolic Syndrome, Camellia-timi 61 +9

Somatomedin C in Treated Acromegaly: Poor Correlation with Growth Hormone and Clinical Response

Larry D. Stonesifer, Richard M. Jordan, Peter O. Kohler · The Journal of Clinical Endocrinology & Metabolism · 1981 · 54 citations

Somatomedin C, Treated Acromegaly, Pituitary Gland +11

Short-Term Comparison of Once- versus Twice-Daily Administration of Glimepiride in Patients with Non-Insulin-Dependent Diabetes Mellitus

Gabriele E. Sonnenberg, Dyal C. Garg, Donald J. Weidler et al. · Annals of Pharmacotherapy · 1997 · 39 citations